Compare · FONR vs MASI
FONR vs MASI
Side-by-side comparison of Fonar Corporation (FONR) and Masimo Corporation (MASI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both FONR and MASI operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- MASI is the larger of the two at $9.42B, about 75.3x FONR ($125.1M).
- Over the past year, FONR is up 31.9% and MASI is up 4.6% - FONR leads by 27.3 points.
- FONR has been more active in the news (18 items in the past 4 weeks vs 2 for MASI).
- MASI has more recent analyst coverage (24 ratings vs 0 for FONR).
- Company
- Fonar Corporation
- Masimo Corporation
- Price
- $19.10+0.03%
- $179.96+0.63%
- Market cap
- $125.1M
- $9.42B
- 1M return
- +0.90%
- +0.83%
- 1Y return
- +31.91%
- +4.56%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1981
- 2007
- News (4w)
- 18
- 2
- Recent ratings
- 0
- 24
Fonar Corporation
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
Masimo Corporation
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. The company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. The company offers coronavirus-2019 response and telehealth solutions; connectivity devices; and nasal high flow ventilation and neuromodulation solutions. The company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, physician offices, long term care facilities, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. Incorporated in 1989, the company is headquartered in Irvine, California.
Latest FONR
- SEC Form 4 filed by Director Turk Richard E.
- SEC Form 3 filed by new insider Turk Richard E.
- SEC Form 4 filed by EVP/COO/Acting PFO Bonanni Luciano B
- EVP/COO Bonanni Luciano B was granted 47,226 units of FONAR CORPORATION COMMON STOCK, increasing direct ownership by 2,029% to 49,553 units (SEC Form 4)
- New insider Bonanni Luciano B claimed ownership of 2,327 units of FONAR CORPORATION COMMON STOCK (SEC Form 3)
- SEC Form 4 filed by President/CEO/Treasurer Damadian Timothy Raymond
- President/CEO/Treasurer Damadian Timothy Raymond was granted 26,000 units of FONAR CORPORATION COMMON STOCK and transferred by will 36,359 units of FONAR CORPORATION COMMON STOCK), increasing direct ownership by 559% to 79,059 units (SEC Form 4)
- New insider Damadian Timothy Raymond claimed ownership of 12,000 units of FONAR CORPORATION COMMON STOCK (SEC Form 3)
- Large owner Shane Hilary bought $4,113,298 worth of shares (215,336 units at $19.10) (SEC Form 4)
- SEC Form S-8 POS filed by Fonar Corporation
Latest MASI
- Sirius XM Holdings Set to Join S&P MidCap 400
- SEC Form SD filed by Masimo Corporation
- SEC Form SCHEDULE 13G filed by Masimo Corporation
- SEC Form 10-Q filed by Masimo Corporation
- Director Scannell Timothy J converted options into 1,225 shares, increasing direct ownership by 89% to 2,608 units (SEC Form 4)
- Director Lane Wendy E converted options into 1,225 shares, increasing direct ownership by 89% to 2,608 units (SEC Form 4)
- Chairman of the Board Brennan Michelle converted options into 1,225 shares, increasing direct ownership by 17% to 8,543 units (SEC Form 4)
- Chief Human Resources Officer Hellmann Elisabeth A converted options into 335 shares and covered exercise/tax liability with 121 shares (SEC Form 4) to satisfy tax liability
- Masimo Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits
- Masimo Shareholders Approve Acquisition by Danaher